Since 1996 WHN is the second oldest medical website on the net, second only to the American Medical Association, servicing over 35,000 physicians and scientists worldwide.
Non-Profit Trusted Source of Non-Commercial Health Information
We recently attended RAADfest in Las Vegas, Nevada and were able to speak with Dr. Joshua Hare co-founder of Longeveron, who talked to us about some of their very important research with stem cells in the medical condition aging frailty. The following is an excerpt from his presentation and interview. Longeveron is sponsoring FDA authorized, …
Aging can be seen as one of the biggest risk factors for developing many diseases such as cancer, osteoporosis, cardiovascular disease, and Alzheimer’s disease. Therapies targeting aging may help to reduce suffering and benefit humanity. Longevity drug development has evolved into an industry priority, as such a number of companies are working on developing therapies …
J147, the molecular targeting drug, has been shown to treat Alzheimer’s disease and reverse aging in mice is nearing readiness for the clinical trials in humans. Scientists have been able to determine what exactly J147 does,reporting that the drug binds to a protein found within the mitochondria which is the energy generating powerhouse of the …